EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Computational and artificial intelligence-based methods for antibody development

Jisun Kim, Matthew McFee, Qiao Fang, Osama Abdin, Philip M Kim

Trends in Pharmacological Sciences · 2023-03 · 44 (3) · 175-189

DOI: 10.1016/j.tips.2022.12.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2023-03. Verfasst von Jisun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto M5S 3E1, Canada. Hauptthemen laut MEDLINE: Artificial Intelligence, Antibodies. Die Arbeit wurde bisher 191-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to their high target specificity and binding affinity, therapeutic antibodies are currently the largest class of biotherapeutics. The traditional largely empirical antibody development process is, while mature and robust, cumbersome and has significant limitations. Substantial recent advances in computational and artificial intelligence (AI) technologies are now starting to overcome many of these limitations and are increasingly integrated into development pipelines. Here, we provide an overview of AI methods relevant for antibody development, including databases, computational predictors of antibody properties and structure, and computational antibody design methods with an emphasis on machine learning (ML) models, and the design of complementarity-determining region (CDR) loops, antibody structural components critical for binding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceAntibodiesHumansComplementarity Determining RegionsMachine Learning

Stichwörter der Autor:innen

antibody developmentartificial intelligencecomputational engineeringdeep learning

Substanzen

AntibodiesComplementarity Determining Regions

Autor:innen und Institutionen

  • Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto M5S 3E1, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto M5S 1A8, Canada.
  • Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto M5S 3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto M5S 1A8, Canada; Department of Computer Science, U…

Förderung

  • CIHR

Zitieren

APA

Kim, J., McFee, M., Fang, Q., Abdin, O., & Kim, P. M. (2023). Computational and artificial intelligence-based methods for antibody development. Trends in Pharmacological Sciences, 44(3), 175-189. https://doi.org/10.1016/j.tips.2022.12.005

Vancouver

Kim J, McFee M, Fang Q, Abdin O, Kim PM. Computational and artificial intelligence-based methods for antibody development. Trends in Pharmacological Sciences. 2023;44(3):175-189. doi:10.1016/j.tips.2022.12.005

BibTeX
@article{Kim2023,
  author = {Kim, Jisun and McFee, Matthew and Fang, Qiao and Abdin, Osama and Kim, Philip M},
  title = {Computational and artificial intelligence-based methods for antibody development},
  journal = {Trends in Pharmacological Sciences},
  year = {2023},
  volume = {44},
  number = {3},
  pages = {175--189},
  doi = {10.1016/j.tips.2022.12.005}
}
Kostenlos starten →